Viela Bio, Inc. Common Stock
VIE
VIE was delisted on the 12th of March, 2021.
65 hedge funds and large institutions have $962M invested in Viela Bio, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 8 closing their positions.
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
32% more capital invested
Capital invested by funds: $729M → $962M (+$233M)
32% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 19
8% more funds holding
Funds holding: 60 → 65 (+5)
1.27% more ownership
Funds ownership: 47.5% → 48.77% (+1.3%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $14K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$18.2M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$9.98M |
| 3 |
SCM
Segantii Capital Management
Hong Kong
|
+$4.91M |
| 4 |
Goldman Sachs
New York
|
+$4.64M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$12.8M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$5.46M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$4.89M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.73M |
| 5 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$3.34M |
VIE Hedge Fund Activity: Q4 2020 in Review
65 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Viela Bio, Inc. Common Stock (VIE) for Q4 2020, worth a combined $962M — up 32% from $729M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new VIE positions and 8 closed out — a net gain of 5 holders — while 25 added to existing stakes and 19 trimmed.
The largest buyer was BlackRock, adding an estimated $18.2M. The largest seller was State Street, cutting an estimated $12.8M.
- 65 institutional investors held Viela Bio, Inc. Common Stock (VIE) as of Q4 2020, up from 60 in Q3 2020.
- Funds reported $962M of Viela Bio, Inc. Common Stock stock for Q4 2020, up 32% quarter-over-quarter.
- 13 funds opened new Viela Bio, Inc. Common Stock positions in Q4 2020 and 8 closed out, a net change of +5 holders.
- The largest Viela Bio, Inc. Common Stock buyer in Q4 2020 was BlackRock, an estimated $18.2M added.
- The largest Viela Bio, Inc. Common Stock seller in Q4 2020 was State Street, an estimated $12.8M sold.
Based on aggregated 13F filings for Q4 2020.